Published in Arch Neurol on April 01, 1996
Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology (2006) 1.37
Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (2010) 1.31
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry (2002) 1.14
Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly. J Neurol Neurosurg Psychiatry (2004) 1.06
Relationship between white-matter hyperintensities and hematoma volume and growth in patients with intracerebral hemorrhage. Stroke (2009) 0.93
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals. J Cereb Blood Flow Metab (2016) 0.88
Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol (2001) 0.87
Increased visibility of deep medullary veins in leukoaraiosis: a 3-T MRI study. Front Aging Neurosci (2014) 0.85
Brain iron deposition in white matter hyperintensities: a 3-T MRI study. Age (Dordr) (2012) 0.83
Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia. AJNR Am J Neuroradiol (1999) 0.81
Intracerebral microdialysis and CSF hydrodynamics in idiopathic adult hydrocephalus syndrome. J Neurol Neurosurg Psychiatry (2003) 0.81
Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease. J Neurol Neurosurg Psychiatry (2000) 0.79
White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies. Neurobiol Aging (2016) 0.75
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med (2001) 13.85
Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (1998) 11.27
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med (1999) 7.74
Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80
Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet (2004) 5.93
Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet (2003) 5.90
The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med (2000) 4.67
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med (1995) 3.54
The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients. Stroke (1999) 3.31
Sample size requirements for reliability studies. Stat Med (1987) 3.15
Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology (1996) 2.89
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA (2000) 2.56
The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med (1997) 2.52
Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain (1992) 2.33
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Effects of supporting community-living demented patients and their caregivers: a randomized trial. J Am Geriatr Soc (2001) 2.28
CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology (2001) 2.27
Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.26
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med (1998) 2.20
A goodness-of-fit approach to inference procedures for the kappa statistic: confidence interval construction, significance-testing and sample size estimation. Stat Med (1992) 2.20
The pathology and nosology of primary progressive aphasia. Neurology (1994) 2.11
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Hospital volume and stroke outcome: does it matter? Neurology (2007) 2.07
Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke (2006) 2.07
Low-dose aspirin and stroke. "It ain't necessarily so". Stroke (1992) 2.04
Randomised trialomania? The multicentre liver transplant trials of tacrolimus. Lancet (1995) 2.04
The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology (2000) 2.04
The upgoing thumb sign. Arch Neurol (1992) 2.03
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology (2001) 1.98
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry (2003) 1.90
Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology (2010) 1.88
Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry (2005) 1.86
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol (1993) 1.86
Human rabies of bat origin in Europe. Lancet (1986) 1.85
Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol (1986) 1.83
A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J (2000) 1.79
Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet (1992) 1.78
Cerebral hemispheric lateralization in cardiac autonomic control. Arch Neurol (1997) 1.78
The Canadian Neurological Scale: validation and reliability assessment. Neurology (1989) 1.78
Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology (2000) 1.76
Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc (1987) 1.76
A new definition of Alzheimer's disease: a hippocampal dementia. Lancet (1985) 1.73
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71
Drugs and surgery in the prevention of ischemic stroke. N Engl J Med (1995) 1.71
Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients. Neurology (2007) 1.66
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Cerebral microbleeds: histopathological correlation of neuroimaging. Cerebrovasc Dis (2011) 1.63
Prevalence of severe dementia in Finland. Neurology (1985) 1.62
Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke (2002) 1.61
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol (1995) 1.60
Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS (1995) 1.59
The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol (1995) 1.59
Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry (1983) 1.59
Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann Neurol (1998) 1.56
Improved outcomes in stroke thrombolysis with pre-specified imaging criteria. Can J Neurol Sci (2001) 1.53
Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain. J Neuropathol Exp Neurol (1995) 1.52
APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology (2000) 1.51
Complications of acute stroke. Lancet (1992) 1.50
The dilemma of surgical treatment for patients with asymptomatic carotid disease. Ann Intern Med (1995) 1.50
Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med (1990) 1.50
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol (2000) 1.49
Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology (2000) 1.49
Anterior cruciate ligament tear: prospective evaluation of diagnostic accuracy of middle- and high-field-strength MR imaging at 1.5 and 0.5 T. Radiology (1995) 1.49
Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. N Engl J Med (1991) 1.48
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
Stroke treatment: time is brain. Lancet (1998) 1.44
Environmental exposures in elderly Canadians with Parkinson's disease. Can J Neurol Sci (1995) 1.43
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis (2001) 1.41
Infantile type of so-called neuronal ceroid-lipofuscinosis. Dev Med Child Neurol (1974) 1.39
Does the neurologist add value to the carotid endarterectomy patient? Neurology (1998) 1.39
Are the results of the extracranial-intracranial bypass trial generalizable? N Engl J Med (1987) 1.39
More about: cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst (2000) 1.39
Medical treatment of cysticercosis. Arch Neurol (1995) 1.38
An autopsy-verified study of the effect of education on degenerative dementia. Brain (1999) 1.38
The identification by imaging methods of patients who might benefit from carotid endarterectomy. Arch Neurol (1995) 1.37
An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet (1995) 1.36
Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry (1987) 1.36
Incidence of second hip fractures. A population-based study. Osteoporos Int (2007) 1.35
Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study. Neurology (2007) 1.34
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology (2001) 1.33
Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol (1996) 1.32
Progressive myoclonus epilepsy. A clinical and histopathological study. Acta Neurol Scand (1974) 1.32
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol (2000) 1.32
Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc Natl Acad Sci U S A (1993) 1.31
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
Joint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and Aging. Neurology (2007) 1.30
Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest (1992) 1.30
Intracranial hemangiopericytoma: radiology, surgery, radiotherapy, and outcome in 21 patients. Surg Neurol (1985) 1.29